KMKasra Mehdizadeh

Kasra Mehdizadeh

*This is an algorithmically generated author record based on publicly available information.

Kasra Mehdizadeh has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Alireza Salmanipour

    Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran 1995614331, Iran

    1 shared publication
  • Bahram Mohebbi

    Vascular Diseases and Thrombosis Research Center Rajaie Cardiovascular Institute Tehran Iran

    1 shared publication
  • Danial Farmani

    Vascular Diseases and Thrombosis Research Center Rajaie Cardiovascular Institute Tehran Iran

    1 shared publication
  • Frederikus A. Klok

    Department of Medicine‐Thrombosis and Hemostasis Leiden University Medical Center Leiden The Netherlands

    1 shared publication
  • Hamid Reza Pouraliakbar

    Vascular Diseases and Thrombosis Research Center Rajaie Cardiovascular Institute Tehran Iran

    1 shared publication
  • Hooman Bakhshandeh

    Vascular Diseases and Thrombosis Research Center Rajaie Cardiovascular Institute Tehran Iran

    1 shared publication

Latest Publications

  • Open Access

    The Trace of c.3747_3748insGG Variation of the MYBPC3 Gene in the Family With Atrioventricular Canal Defect

    by MohammadHossein MozafaryBazargany, Maryam Pourirahim, Alireza Salmanipour, Kasra Mehdizadeh, Mohammad Mahdavi, Mohammadrafie Khorgami, Majid Maleki, Samira Kalayinia

    Background: Atrioventricular canal defect (AVCD) is a congenital heart disease often associated with genetic changes, with a broad spectrum of anatomical patterns. Aim: We present a novel likely pathogenic variant of MYBPC3 in a proband with AVCD. Methods: A clinical and genetic evaluation was conducted on a one‐year‐old Iranian girl referred to our center with cardiac structural abnormalities and her family. Transthoracic echocardiography (TTE) and cardiac computed tomography (CT) were employed for clinical evaluation, and whole exome sequencing (WES), polymerase chain reaction (PCR), and Sanger sequencing were utilized for genetic analysis. Results: TTE revealed a ventricular and atrial septal defect (ASD), along with pulmonary hypertension (PH). The proband was diagnosed with AVCD through cardiac CT. WES identified a novel heterozygous MYBPC3 (NM_000256.3): c.3747_3748insGG; p.(Ile1250Glyfs∗82). Segregation analysis confirmed the presence of the same variant in the proband’s father, who was diagnosed with hypertrophic cardiomyopathy (HCM). Conclusion: We presented the first case of AVCD associated with a novel MYBPC3 variant, expanding the spectrum of cardiac anomalies linked to MYBPC3 mutations. The findings highlight the complexity and variable expression of MYBPC3 within affected family members.

  • Open Access

    3‐year quality of life, functional performance, and long‐term survival after acute pulmonary embolism; A prospective study

    by Kasra Mehdizadeh, Sepideh Kalantari, Mahsa Mohammadi, Melody Farrashi, Raheleh Kaviani, Danial Farmani, Mona Naghshbandi, Jamal Moosavi, Bahram Mohebbi, Hooman Bakhshandeh, et al.

    Our prospective study investigates the 3‐year trajectory of disease‐specific quality of life (QoL) using the PEmb‐QoL questionnaire, functional performance via 6‐min walk tests, and the 5‐year survival following acute pulmonary embolism (PE) and explores their association with patient demographics and clinical characteristics. We highlight that PE‐specific QoL improves over time despite no significant changes in cardiopulmonary performance.